Designing a cell therapy trial that satisfies Project Optimus
Dose optimization expectations have changed, and cell therapy programs face the added complexity of a conditioning regimen that is rarely optimized. See how Certara’s clinical pharmacology and trial design teams help sponsors build Phase 1/2 studies that answer the dose question the first time.
